Lin Patrick

Chief Business - Strategy Off

Lin Patrick has filed 8 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2026. 8 of those filings fall inside the rolling window. Most recent filing: Jul 1, 2026.

On the most recent filing, Lin Patrick is listed as Chief Business - Strategy Off at Processa Pharmaceuticals, Inc. Inside the rolling window, Lin Patrick reported 7 open-market purchases totaling $28K in PCSA and no open-market sales. The largest disclosed transaction in the window is a purchase of 1,369 PCSA shares on May 15, 2026, worth $4K.

Companies traded

Other insiders at PCSA

Insider Buying

$28K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
PCSAPurchase$4KJul 1SEC ↗
PCSAPurchase$4KJun 16SEC ↗
PCSAPurchase$4KJun 1SEC ↗
PCSAPurchase$4KMay 19SEC ↗
PCSAPurchase$4KMay 1SEC ↗
PCSAPurchase$4KApr 17SEC ↗
PCSAPurchase$4KApr 1SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Lin Patrick made?

Lin Patrick has filed 8 SEC Form 4 filings (8 transaction rows) across 1 company since 2026.

Which companies does Lin Patrick trade?

Lin Patrick has filed SEC Form 4 disclosures for 1 company, including PCSA.

When was Lin Patrick's most recent SEC Form 4 filing?

Lin Patrick's most recent SEC Form 4 filing on Tracefour is dated Jul 1, 2026.

What is Lin Patrick's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Lin Patrick is listed as Chief Business - Strategy Off.

What is Lin Patrick's total buy and sell value in the current window?

Inside the rolling retention window, Lin Patrick bought $28K and sold $0 based on SEC Form 4 filings.

What was Lin Patrick's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 1,369 PCSA shares on 2026-05-15, worth $4K, per SEC Form 4 filings.